Jaguar Health Inc (JAGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,724 | -24,737 | -12,629 | -49,075 | -40,163 |
| Depreciation Amortization | 13,293 | 5,581 | 1,827 | 14,050 | 10,481 |
| Accounts receivable | 622 | 918 | 1,030 | -421 | -452 |
| Accounts payable and accrued liabilities | -670 | -1,160 | -134 | 902 | 1,391 |
| Other Working Capital | -7,771 | -2,176 | -179 | -4,428 | -2,109 |
| Other Operating Activity | 1,459 | 2,573 | 140 | 5,868 | 4,171 |
| Operating Cash Flow | $-25,791 | $-19,001 | $-9,945 | $-33,104 | $-26,681 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -77 | -77 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,598 | -1,237 |
| Other Investing Activity | 0 | 0 | 0 | -1,598 | -1,237 |
| Investing Cash Flow | $N/A | $0 | $N/A | $-1,675 | $-1,314 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 3,975 | 3,975 |
| Common Stock Issued | 22,082 | 20,653 | 17,865 | 20,462 | 17,786 |
| Other Financing Activity | 1,495 | 1,515 | 946 | -1,256 | -218 |
| Financing Cash Flow | $23,577 | $22,168 | $18,811 | $23,181 | $21,543 |
| Exchange Rate Effect | -29 | -9 | 32 | 16 | -38 |
| Beginning Cash Position | 5,469 | 5,469 | 5,469 | 17,051 | 17,051 |
| End Cash Position | 3,226 | 8,627 | 14,367 | 5,469 | 10,561 |
| Net Cash Flow | $-2,243 | $3,158 | $8,898 | $-11,582 | $-6,490 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,791 | -19,001 | -9,945 | -33,104 | -26,681 |
| Capital Expenditure | N/A | 0 | N/A | -77 | -77 |
| Free Cash Flow | -25,791 | -19,001 | -9,945 | -33,181 | -26,758 |